The launch of phase '0' trials has generated much discussion in the cancer research community. This Perspective, written by scientists at the US National Cancer Institute, discusses the aims of these trials, gives some practical advice for conducting them and addresses several outstanding questions.
- Shivaani Kummar
- Robert Kinders
- James H. Doroshow
